文献速递心力衰竭与心肌病

植入式血流动力学监测用于心力衰竭患者

Implantable Hemodynamic Monitoring for Heart Failure Patients.
PubMed 文献 · J Am Coll Cardiol · 2017-01-01

本文综述植入式血流动力学监测在心力衰竭管理中的应用。非侵入性远程医疗系统未能降低住院率,而心内和肺动脉压力引导的管理成为减少心衰住院的焦点。早期研究显示压力管理的潜力,后续研究证实其临床效用,一项大型关键试验证明肺动脉压力引导管理安全有效,显著降低心衰住院。

要点

  • 非侵入性远程医疗系统未能证明降低心衰住院率。
  • 肺动脉压力引导管理在关键试验中显著降低心衰住院。
  • 下一代植入式血流动力学监测器正在开发中。

核心结论

  • 肺动脉压力引导的心衰管理可显著降低心衰住院率,且安全有效。

研究设计与样本

  • 综述类文章,未报告系统检索范围与样本量。

主要发现

  • 非侵入性远程医疗系统随机对照试验未能证明降低住院率。
  • 早期植入式血流动力学监测研究显示压力管理潜力。
  • 一项大型关键试验证明肺动脉压力引导管理安全有效,显著降低心衰住院。

临床怎么用

  • 对于心衰患者,可考虑使用植入式肺动脉压力监测指导管理以减少住院。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rates of heart failure hospitalization remain unacceptably high. Such hospitalizations are associated with substantial patient, caregiver, and economic costs. Randomized controlled trials of noninvasive telemedical systems have failed to demonstrate reduced rates of hospitalization. The failure of these technologies may be due to the limitations of the signals measured. Intracardiac and pulmonary artery pressure-guided management has become a focus of hospitalization reduction in heart failure. Early studies using implantable hemodynamic monitors demonstrated the potential of pressure-based heart failure management, whereas subsequent studies confirmed the clinical utility of this approach. One large pivotal trial proved the safety and efficacy of pulmonary artery pressure-guided heart failure management, showing a marked reduction in heart failure hospitalizations in patients randomized to active pressure-guided management. "Next-generation" implantable hemodynamic monitors are in development, and novel approaches for the use of this data promise to expand the use of pressure-guided heart failure management.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Abraham WT, Perl L. Implantable Hemodynamic Monitoring for Heart Failure Patients. J Am Coll Cardiol. 2017. PMID: 28705321. doi:10.1016/j.jacc.2017.05.052

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。